Work

Banoxantrone (AQ4N), tissue CYP 450 targeted prodrug: The results of a phase I study using an accelerated dose escalation

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.2011

Authors: J. Sarantopoulos, A. W. Tolcher, A. Wong, S. Goel, M. Beeram, G. Lam, K. Desai, K. Woody, S. Mani, K. P. Papadopoulos

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, The University of Texas at San Antonio Health Science Center, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2941778486

Cites:

Cited by: 8

Related to: 10